TruVenturo
VC Fund
Hamburg, Germany
TruVenturo is an entrepreneurial investor and company builder in Europe and the United States
- Total investments:
- 19
- Last investment:
- Lead investor:
- 11%
Last updated:
For AI agents: llms.txt
Industries TruVenturo invests in
Stages TruVenturo invests in
Countries TruVenturo invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
3 more contacts available
Round size
- Seed
- $1.1M–$24M
- Series A
- $2.4M–$20M
- Venture - Series Unknown
- $12M–$45M
Investment Focus
Industry
- Travel 2 (11%)
- Tourism 2 (11%)
- Software 2 (11%)
- E-Commerce 2 (11%)
- Hospitality 2 (11%)
Stage
- Seed 5 (26%)
- Series A 5 (26%)
- Venture - Series Unknown 2 (11%)
- Pre-Seed 1 (5%)
- Series B 1 (5%)
Country
- Germany 9 (47%)
- United States 2 (11%)
- Spain 1 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Felix Schneider
Managing Director & Partner
|
Managing Director & Partner | Total investments: 0 | Find email | |
Nils Regge
Founder & Chief Executive Officer
|
Founder & Chief Executive Officer | Total investments: 4 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Tomorrow Bio
|
Tomorrow Bio is a Biotech firm that specializes in human cryopreservation. They use cutting-edge technology to keep you alive in the future. | $5.6M / Seed / May 22, 2025 | |
Rune Labs
|
Rune Labs is a software and data platform for neuromodulation and brain therapies of the future. The platform's software-as-a-service platform works with existing and emerging neuromodulation systems to manage complex therapies and get the most value out of available data. Their cloud-based software platform provides these therapy developersthe performance, scalability, and availability they need to run complex therapy algorithms across many patients, deliver precision medicine, and identify likely responders for clinical trials.Rune Labs was founded in 2018 and is headquartered in San Francisco, California. | $12M / Venture - Series Unknown / Jan 11, 2024 | |
get.me
|
get.me connects social media accounts or links to sites. They create a free link in their bio page that earns money and turns followers into paying subscribers, so they earn money from social media with every subscriber. | $769.7K / Pre-Seed / Aug 01, 2022 | |
MYNE Homes
|
MYNE Homes is a digital co-ownership platform for vacation properties. MYNE Homes was founded in 2021 and was headquartered in Berlin, Germany. | $23.9M / Seed / Jul 07, 2022 | |
Numa
|
NUMA Group is Germany's leading technology provider in the short term rental sector and driver of the new asset class Commercial Living. NUMA combined the comfort of a home with the standards of a hotel. NUMA develops new technology solutions for the real estate industry, focusing on hotels and apartment rentals. NUMA automates operationalprocesses by up to 80 percent, enabling hotel operators to save up to 60 percent through restructuring. In addition, NUMA can drive up to 40 percent in additional topline revenue. In 2020, NUMA achieved 90 percent booking occupancy even during Corona-related lockdown. | $45.1M / Venture - Series Unknown / Feb 07, 2022 | |
CereGate
|
CereGate is a Brain-Machine Interface company establishing new ways of communication. | Series A / Jan 12, 2022 | |
|
CereGate
|
CereGate is a Brain-Machine Interface company establishing new ways of communication. | Convertible Note / Jan 12, 2022 | |
INBRAIN Neuroelectronics
|
INBRAIN Neuroelectronics is pioneering real time precision neurology with the world’s first graphene-based brain-computer interface (BCI) therapeutics platform. Our technology combines precise BCI decoding with micrometric modulation to deliver adaptive, personalized treatments for conditions such as Parkinson’s disease, epilepsy, and strokerehabilitation. By providing continuous real-time monitoring and autonomous therapy adjustments, our AI-driven platform maximizes therapeutic outcomes while minimizing side effects. Through strategic collaborations, including with Merck KGAa and our subsidiary INNERVIA Bioelectronics, we are extending our innovative solutions to peripheral nerve and systemic disease applications, unlocking the potential of neurotechnology and bioelectronics. For more information, visit www.inbrain-neuroelectronics.com and follow us on LinkedIn. | $19.8M / Series A / Mar 26, 2021 | |
|
Rune Labs
|
Rune Labs is a software and data platform for neuromodulation and brain therapies of the future. The platform's software-as-a-service platform works with existing and emerging neuromodulation systems to manage complex therapies and get the most value out of available data. Their cloud-based software platform provides these therapy developersthe performance, scalability, and availability they need to run complex therapy algorithms across many patients, deliver precision medicine, and identify likely responders for clinical trials.Rune Labs was founded in 2018 and is headquartered in San Francisco, California. | $5M / Seed / Oct 26, 2020 | |
|
CereGate
|
CereGate is a Brain-Machine Interface company establishing new ways of communication. | Series A / Sep 03, 2020 | |
| See all 19 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does TruVenturo invest in?
TruVenturo invests primarily in Travel, Tourism and Software startups, most often at Seed and Series A stage. Most of the 19 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is TruVenturo's check size?
TruVenturo typically joins rounds of $1.1M–$24M at Seed, $2.4M–$20M at Series A and $12M–$45M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds TruVenturo participates in.
How do I contact TruVenturo?
Public channels for TruVenturo include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at TruVenturo?
The team at TruVenturo includes Felix Schneider (Managing Director & Partner) and Nils Regge (Founder & Chief Executive Officer). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
